Literature DB >> 18278481

A new role for extracellular Ca2+ in gap-junction remodeling: studies in humans and rats.

S Dhein1, N Duerrschmidt, A Scholl, A Boldt, J S Schulte, B Pfannmüller, D Rojas-Gomez, A Scheffler, J-A Haefliger, N Doll, F-W Mohr.   

Abstract

We wanted to elucidate whether extracellular calcium may regulate the expression of the cardiac gap-junction proteins connexin 40 and connexin43. In the free wall of the left atria of 126 cardiac surgery patients with either sinus rhythm (SR) or chronic atrial fibrillation (AF), we determined the expression of the cardiac gap-junction proteins Cx43 and Cx40 by Western blot and immunohistology. For deeper investigation, we incubated cultured neonatal rat cardiomyocytes at 2 or 4 mM Ca(++) for 24 h and determined intercellular coupling, Cx40, Cx43 protein and mRNA expression, protein trafficking and sensitivity to verapamil (10-100 nM), cyclosporin A (1 microM),and BMS605401 (100 nM), a specific inhibitor of Ca(2+)-sensing receptor (CaSR). We found in patients that both Cx are up-regulated in AF in the left atrium (by 100-200%). Interestingly, Cx40 was mainly up-regulated, if total serum calcium was >or=2.2 mM, while Cx43 was independent from extracellular [Ca(++)]. In cultured cells, 4 mM Ca(++)-exposure lead to up-regulation of Cx40, but not Cx43. We found enhanced Cx40 in the plasma membrane and reduced Cx40 in the Golgi apparatus. The membrane Cx40 up-regulation resulted in enhanced gap-junction intercellular coupling with a shift in the Boltzmann fit of voltage-dependent inactivation indicating a higher contribution of Cx40 as revealed by dual whole cell voltage clamp experiments. BMS605401 could prevent all Ca(2+)-induced changes. Moreover, cyclosporin A completely abolished the Ca(2+)-induced changes, while verapamil was ineffective. We conclude that extracellular calcium (24 h exposure) seems to up-regulate Cx40 but not Cx43.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278481     DOI: 10.1007/s00210-008-0265-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  49 in total

1.  Expression and regulation of connexins in cultured ventricular myocytes isolated from adult rat hearts.

Authors:  Lioudmila O Polontchouk; Virginijus Valiunas; Jacques-Antoine Haefliger; Hans M Eppenberger; Robert Weingart
Journal:  Pflugers Arch       Date:  2002-01-15       Impact factor: 3.657

2.  Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies.

Authors:  U Wetzel; A Boldt; J Lauschke; J Weigl; P Schirdewahn; A Dorszewski; N Doll; G Hindricks; S Dhein; H Kottkamp
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

3.  Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation.

Authors:  Stephan Weng; Melani Lauven; Thomas Schaefer; Lioudmila Polontchouk; Rajiv Grover; Stefan Dhein
Journal:  FASEB J       Date:  2002-05-08       Impact factor: 5.191

4.  Expression of connexin 37, 40, and 43 mRNA and protein in renal preglomerular arterioles.

Authors:  B Arensbak; H B Mikkelsen; F Gustafsson; T Christensen; N H Holstein-Rathlou
Journal:  Histochem Cell Biol       Date:  2001-06       Impact factor: 4.304

5.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

6.  Structural correlate of atrial fibrillation in human patients.

Authors:  Sawa Kostin; Gabi Klein; Zoltan Szalay; Stefan Hein; Erwin P Bauer; Jutta Schaper
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

Review 7.  Molecular mechanisms of remodeling in human atrial fibrillation.

Authors:  Bianca J J M Brundel; Robert H Henning; Harm H Kampinga; Isabelle C Van Gelder; Harry J G M Crijns
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

8.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13

9.  Enalapril prevents perpetuation of atrial fibrillation by suppressing atrial fibrosis and over-expression of connexin43 in a canine model of atrial pacing-induced left ventricular dysfunction.

Authors:  Masao Sakabe; Akira Fujiki; Kunihiro Nishida; Masataka Sugao; Hidehiko Nagasawa; Takayuki Tsuneda; Koichi Mizumaki; Hiroshi Inoue
Journal:  J Cardiovasc Pharmacol       Date:  2004-06       Impact factor: 3.105

10.  Connexin-specific distribution within gap junctions revealed in living cells.

Authors:  M M Falk
Journal:  J Cell Sci       Date:  2000-11       Impact factor: 5.285

View more
  3 in total

Review 1.  Monogenic atrial fibrillation as pathophysiological paradigms.

Authors:  Saagar Mahida; Steven A Lubitz; Michiel Rienstra; David J Milan; Patrick T Ellinor
Journal:  Cardiovasc Res       Date:  2010-11-30       Impact factor: 10.787

2.  Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation.

Authors:  S Dhein; S Rothe; A Busch; D M Rojas Gomez; A Boldt; A Reutemann; T Seidel; A Salameh; B Pfannmüller; A Rastan; M Kostelka; F W Mohr
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 3.  The two faces of pannexins: new roles in inflammation and repair.

Authors:  Helen P Makarenkova; Sameer B Shah; Valery I Shestopalov
Journal:  J Inflamm Res       Date:  2018-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.